Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. - Wikidata - awgldk - TriplyDB

Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.

Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.

http://www.wikidata.org/entity/Q48107574

about

Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: an FMRI study Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors Chemotherapy-related cognitive impairment in older patients with cancer Cancer- and cancer treatment-associated cognitive change: an update on the state of the science Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: A functional magnetic resonance imaging study Cognitive function and breast cancer: promise and potential insights from functional brain imaging.Opening up the window into "chemobrain": a neuroimaging review Functional MRI studies in non-CNS cancers.Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations.Default mode network as a potential biomarker of chemotherapy-related brain injury Cognitive impairment and associated loss in brain white microstructure in aircrew members exposed to engine oil fumes.Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusion Prevalence, mechanisms, and management of cancer-related cognitive impairment.Asiatic acid protects against cognitive deficits and reductions in cell proliferation and survival in the rat hippocampus caused by 5-fluorouracil chemotherapy.A meta-analysis of cognitive impairment following adult cancer chemotherapy.A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients.Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation.Altered small-world properties of gray matter networks in breast cancer Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.Diffusion tensor MRI of chemotherapy-induced cognitive impairment in non-CNS cancer patients: a review.Systemic chemotherapy decreases brain glucose metabolism.Neurocognitive dimensions of breast cancer and its treatment Health-related quality of life and cancer clinical trials.Frontal hypometabolism in elderly breast cancer survivors determined by [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET): a pilot study A meta-analysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer.Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults Potential toxicities of prophylactic cranial irradiation.Prefrontal cortex and executive function impairments in primary breast cancer.Associations between catecholaminergic, GABAergic, and serotonergic genes and self-reported attentional function in oncology patients and their family caregivers.Assessing cognitive function in adults during or following chemotherapy: a scoping review.Higher cardiorespiratory fitness levels are associated with greater hippocampal volume in breast cancer survivors.Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study.Changes of Brain Glucose Metabolism in the Pretreatment Patients with Non-Small Cell Lung Cancer: A Retrospective PET/CT Study.Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type.Reduced prefrontal activation during working and long-term memory tasks and impaired patient-reported cognition among cancer survivors postchemotherapy compared with healthy controls.Employment and social benefits up to 10 years after breast cancer diagnosis: a population-based study.Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage.Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study.

P2860

Q21129407-E05DE717-208F-4D32-B001-D3D598A72DA4 Q24594173-8876FE79-C698-4A88-83E4-18335C7646C6 Q26747612-8F3886A7-7862-4A60-97F9-7E0A7F24AB79 Q26853289-3698F4B5-13AB-4B21-8FEA-1BB386FAABA6 Q27011451-5614C3B2-3BD6-4421-A1CE-931DA10154AA Q29395298-54487DA9-05AF-4BBE-BE32-AB010389B920 Q30572890-465E7A30-F31E-4677-9D43-2EFFBFF53E74 Q30596880-9B7BAAF2-DAB2-409B-A52D-C032266EF788 Q30660824-7243AC62-0B53-44D2-B24C-08B05DC2D335 Q30664513-A4E4265C-56D2-400B-B4C9-5FA1595E7F4D Q30830124-37CF1989-94D5-4BB5-92BE-6485F88F4089 Q30969661-AF1656E1-ED8F-4FF2-88C8-813834F4B60D Q33590378-460DBE3B-FDE8-41B4-9074-C1A99BE150C6 Q33854977-4C337CE8-FA7D-49F8-B321-62CED90DAEF5 Q33888300-DA64EDB4-BCC4-4FAE-9A44-6B2A6A9CBF74 Q34083459-9B5E9524-8411-4787-A37E-4A1E17B14DFF Q34110937-4AA488C4-268E-48B7-91C9-535115757062 Q34194470-D7F09F1F-5649-405A-8602-8C9C18F9E2BB Q34282795-9D784FE5-9B27-42B1-BBB4-09E4EEEE6E2A Q34395112-1A9C9200-9B09-46F9-8D27-5319FD0239AC Q34553351-08269D50-416F-4F32-A14B-D7E6E9D45949 Q34562855-5F97E223-9B81-47E4-B81A-276C05B89E40 Q34661127-D56A7C52-EFF9-4958-92A6-36F86CF22007 Q35076356-BC8472D9-2E2F-4E92-856F-430EF5C5299B Q35133442-21BBB417-24C2-4D71-A0E2-A538303E8BFF Q35161191-52EBB5A4-4B00-433D-ADBB-4E436AB8F8D7 Q35164117-FAC74C1A-2C28-4B34-89D5-13E511C8853A Q35200326-33ACF7C5-BA69-4375-8E0E-DD988B4236F8 Q35617310-1535EF62-D4FC-4D2A-8CF8-B32059A2B961 Q35744329-D4AB5259-42CE-4C7B-80E6-F469F5968299 Q35986398-8ECAACDA-57F8-4376-9EFF-6AD19BD83B11 Q35996167-1A45A560-3A25-4A94-902C-2571CDD1E0F4 Q36097701-9404173E-5D6B-4CAC-A762-9CCAE2D0031C Q36104836-57663135-86B5-4072-9AB4-6D552C4F60F0 Q36287777-E4C1EFA2-2DA4-4005-8C35-E09A962BBE34 Q36299321-52BA00D0-A79D-4DDC-8EDF-C34E362176D3 Q36450200-FC1A94D7-9354-4963-9B6F-0FF9451EFE3C Q36473007-6F4BD383-289D-49FC-8113-720D7CA7A190 Q36528154-919E1EC6-9028-45CB-9618-B0F2F06841F0 Q36775693-700157B0-BA0E-4C00-BF99-DF7606C2938E

P2860

Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.

http://www.wikidata.org/entity/Q48107574

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Cerebral hyporesponsiveness an ...... hemotherapy for breast cancer.

@en

Cerebral hyporesponsiveness an ...... hemotherapy for breast cancer.

@nl

type

label

Cerebral hyporesponsiveness an ...... hemotherapy for breast cancer.

@en

Cerebral hyporesponsiveness an ...... hemotherapy for breast cancer.

@nl

prefLabel

Cerebral hyporesponsiveness an ...... hemotherapy for breast cancer.

@en

Cerebral hyporesponsiveness an ...... hemotherapy for breast cancer.

@nl

P1433

Q48107574-FE46374C-54CC-42B0-B668-FF4E9E8429D9

P1476

Q48107574-083A1933-9FFF-4CFF-BE7F-BAFF2AE0D37C

P2093

Q48107574-06EC9D5D-164E-4A91-8FF4-4287BF01D571

Q48107574-33E0E1D3-E958-4A6E-A854-CB51B64B2C8F

Q48107574-3CF3C695-CF85-48F1-8185-7C7021F440B2

Q48107574-3E990D66-06D9-45B1-993E-EEA17E960ECF

Q48107574-418A41F3-AE3C-496D-9A8E-F2CF4F06576E

Q48107574-710C3096-588C-4CF1-905A-958F169EE335

Q48107574-8C9ED0C8-7F79-4D08-9E37-9D354ECB72FE

Q48107574-B2DB9718-32EF-4516-A7FA-AE6EF7EE5D07

P2860

Q48107574-00DDC2CD-3C46-432E-A777-EC2A717E75C0

Q48107574-13D070F5-C740-441A-B2DC-D288C85A424B

Q48107574-2D6988C2-91EE-463F-9C42-6025A0EF5FB0

Q48107574-313920DC-F999-45F9-B210-8A235A23C72E

Q48107574-4972440A-60BD-43A8-8094-108110CA8FC1

Q48107574-4C69CEB1-3BC6-45E5-AF67-809C9378B1E2

Q48107574-5ADF4FE3-4144-4CCA-9B89-CFFD204BB83D

Q48107574-5D546321-C83A-468E-9685-1D2236A9021F

Q48107574-61791CBA-6B95-4D69-88FF-B218A01C1D2A

Q48107574-630F828D-2135-460A-A2BF-50DFB828D3CB

P304

Q48107574-1841EB81-BCFF-4CAD-A52D-9544B2EF8B62

P31

Q48107574-7E291AE8-FBCF-4789-A217-287CE52FA84F

P356

Q48107574-46BADBB2-E8E3-41BC-A225-35DC8C3CCFE9

P433

Q48107574-B6C5CD41-5152-4F34-80D9-7E3DD5FED328

P478

Q48107574-A7CA8ABC-BB55-47D8-997D-054D5556B121

P577

Q48107574-1A5D9BF4-E11D-4405-ABC3-32C81A2D1CB7

P698

Q48107574-63CAA303-CAC6-4773-8220-587BDBBFB1DB

P921

Q48107574-6263F1D7-023B-4B6A-A728-80CD17E34211

P356

P1433

Human Brain Mapping

P1476

Cerebral hyporesponsiveness an ...... hemotherapy for breast cancer.

@en

P2093

Aart J Nederveen

http://www.w3.org/2001/XMLSchema#string

Dick J Veltman

http://www.w3.org/2001/XMLSchema#string

Epie Boven

http://www.w3.org/2001/XMLSchema#string

Frits S A M van Dam

http://www.w3.org/2001/XMLSchema#string

Liesbeth Reneman

http://www.w3.org/2001/XMLSchema#string

Michiel B de Ruiter

http://www.w3.org/2001/XMLSchema#string

Sanne B Schagen

http://www.w3.org/2001/XMLSchema#string

Willem Boogerd

http://www.w3.org/2001/XMLSchema#string

P2860

Cognitive neuropsychology of HIV-associated neurocognitive disorders

Automated Talairach Atlas labels for functional brain mapping

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

Thresholding of statistical maps in functional neuroimaging using the false discovery rate

Specific impairments of planning

Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy

An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

A neuroimaging study of premotor lateralization and cerebellar involvement in the production of phonemes and syllables.

Frontal lobes and human memory: insights from functional neuroimaging.

P304

1206-1219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HBM.21102

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20669165

http://www.w3.org/2001/XMLSchema#string

P921